Novartis Investigative Site

Bern, Switzerland 3010

0 studies enrolling now · 1 studies all time

What they study most

Adenocarcinoma, Carcinoma, Hypernephroid, Nephroid Carcinoma, Renal Cell

Studies at this site

• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed